Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -1.90% is 198% below its 2-year average of 1.93%, near the low end of its 2-year range (-1.90%–3.15%).
243.94% below its 12-month average of 1.32%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.72%.
RETURN ON ASSETS (ROA)
-1.90%
RETURN ON ASSETS (ROA) AVG TTM
1.32%
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-243.94%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.05%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
+93.88%
vs the sector median at left
Park Dental Partners, Inc. Common Stock
Market Cap
$93.26M
Return on Assets (ROA)
-1.90%
TTM Avg
1.32%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$92.54M
Return on Assets (ROA)
-88.24%
TTM Avg
-139.34%
3Y Avg
-100.15%
5Y Avg
-71.92%
Market Cap
$96.60M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.69M
Return on Assets (ROA)
-46.26%
TTM Avg
-55.26%
3Y Avg
-67.06%
5Y Avg
-56.22%
Market Cap
$97.58M
Return on Assets (ROA)
-65.25%
TTM Avg
-70.13%
3Y Avg
-63.89%
5Y Avg
-46.24%
Market Cap
$90.73M
Return on Assets (ROA)
-30.70%
TTM Avg
-50.88%
3Y Avg
-51.94%
5Y Avg
-48.05%
Market Cap
$88.48M
Return on Assets (ROA)
1.69%
TTM Avg
-3.62%
3Y Avg
-6.49%
5Y Avg
-4.78%
Market Cap
$90.16M
Return on Assets (ROA)
-86.56%
TTM Avg
-66.44%
3Y Avg
-84.84%
5Y Avg
-75.69%
Market Cap
$89.81M
Return on Assets (ROA)
-169.86%
TTM Avg
-100.47%
3Y Avg
-69.80%
5Y Avg
-64.10%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.26M | -1.90% | 1.32% | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $92.54M | -88.24% | -139.34% | -100.15% | -71.92% |
| Conexeu Sciences Inc. (CNXU)vs › | $96.60M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.69M | -46.26% | -55.26% | -67.06% | -56.22% |
| Korro Bio, Inc. (KRRO)vs › | $97.58M | -65.25% | -70.13% | -63.89% | -46.24% |
| Equillium, Inc. (EQ)vs › | $90.73M | -30.70% | -50.88% | -51.94% | -48.05% |
| ImmuCell Corporation (ICCC)vs › | $88.48M | 1.69% | -3.62% | -6.49% | -4.78% |
| electroCore, Inc. (ECOR)vs › | $90.16M | -86.56% | -66.44% | -84.84% | -75.69% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.81M | -169.86% | -100.47% | -69.80% | -64.10% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.06M | -91.66% | -48.70% | -37.97% | -29.79% |
ROA
-1.9%
ROE
-11.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.18% |
| 2024-12-31 | 2.82% |
| 2023-12-31 | 3.15% |
